Max Gelman

Senior Editor

AS SEEN ON

Preston's Summary

Max Gelman is a Senior Editor at Endpoints News. He specializes in themes related to medicine and healthcare, pharmaceuticals, and business and economics, with a focus on pharmaceutical manufacturing, regulation, and healthcare administration. Max's insights and analyses have been featured in Endpoints News, NewsBreak, and the World Wealth Journal.

Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston

Geo Focus

United States (National)

Coverage Attributes:

Beta
Informative: 60 %
Reviews: 19 %
Data Driven: 9 %
Opinion: 5 %
Promotional: 4 %

Themes Covered:

Not enough data icon

Not enough data

Most Recent Topics:

  • Pharmaceutical Manufacturing
  • Pharmaceutical Regulation
  • Healthcare Administration
  • Startups
  • Corporate Finance
  • Corporations
  • Entrepreneurship
  • Public Health

Pitching Insights

Max Gelman's articles predominantly cover the healthcare and pharmaceutical industry, with a focus on clinical trials, drug development, and medical research. His coverage heavily relies on cited data and press releases from private sector announcements.

Given Max's reliance on data-driven content, he is likely to be receptive to pitches that offer exclusive access to new findings or insights based on extensive data analysis within the healthcare and pharmaceutical sectors. Additionally, providing expert commentary or analysis of trends in biotech, pharmaceuticals, clinical trials or medical research might also capture his interest.

As Max does not have a specified geographic focus but seems to cover global developments in the industry; therefore sources with an international perspective may resonate well with him.

This information evolves through artificial intelligence and human feedback. Improve this profile .

Journalists With Similar Coverage:

Based on similarity of content.
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Adam Feuerstein
Senior Writer, National Biotech Columnist
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data